# Use of Integrated PET/CT as a First Line Staging and Re-staging Technique in Oncologic Patient.

> **NCT06168877** · — · COMPLETED · sponsor: **IRCCS San Raffaele** · enrollment: 30 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Execution of 18F-FDG PET/CT and contrast-enhanced CT scan.

## Key facts

- **NCT ID:** NCT06168877
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10-21
- **Primary completion:** 2014-07-03
- **Final completion:** 2014-07-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06168877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06168877, "Use of Integrated PET/CT as a First Line Staging and Re-staging Technique in Oncologic Patient.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06168877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*